Actos jury says Takeda failed at safety warnings, but judge tosses $1.7M verdict

Tracy Staton The jury has spoken in the latest Actos trial, and the verdict was this: Takeda Pharmaceutical didn't properly flag the risks of its diabetes drug, and Takeda should ...

Principal unmet needs still outstanding for Alzheimer’s patients

mia.burns By Mia Burns (mia.burns@ubm.com) In the world of treating mild to moderate Alzheimer’s disease, the drugs offering a greater effect on cognition and function compared with ...

Nektar Therapeutics shares crash on PhII pain drug trial flop

John Carroll FierceBiotech News

Pfizer plant in Australia set to be axed

Eric Palmer The U.S. drugmaker will close a plant in Sydney, Australia, in 2015, whacking 140 jobs. FiercePharma News

Are side effects warnings good for sales? In TV ads, yes

Tracy Staton This is either a story about the virtues of honesty or the ever-changing minds of the American consumer. That litany of drug side-effects that's delivered rapid-fire ...

‘Our Commercial Model Is Focused On The Right Things:’ Glaxo’s Rawcliffe Explains

esilverman The last year has proved quite interesting and, in many ways, quite crucial for GlaxoSmithKline. The drugmaker is counting on a spate of new products to win approval ...

Allergan bags neurotoxin products in $362M licensing deal with Medytox

John Carroll Building on its expertise in neurotoxins, Allergan has in-licensed some new product candidates in a deal with Korea's Medytox. Allergan is paying $ 65 million upfront, ...

FDA names Kashmir-born official to head India operations

Eric Palmer The FDA has selected Altaf Ahmed Lal, an Indian-born Ph.D., to take over management of its expanding operations in India. Lal says collaboration with Indian regulators and ...

FDA Adds New Boxed Warnings to Arzerra, Rituxan

barbara.lempert Arzerra (ofatumumab) and Rituxan (rituximab): Drug Safety Communication – New Boxed Warning, Recommendations to Decrease Risk of Hepatitis B Reactivation AUDIENCE: ...

Eli Lilly plans low-cost launch strategy for new diabetes drugs

John Carroll As Lilly Diabetes President Enrique Conterno tells Bloomberg, the company plans to lean on its broad product portfolio to grow sales, rather than sending out legions of ...

If ex-Intermune CEO’s conviction goes to the Supreme Court, who wins?

Tracy Staton Does free speech apply to pharma marketing? Last year, a U.S. appeals court ruled that it does–and that sales reps and drugmakers that tout drugs for off-label use ...

Biosearch Technologies Acquires Majority Stake in LightSpeed Genomics

barbara.lempert PETALUMA, CA (Wednesday, September 25, 2013) – Biosearch Technologies, Inc. (Biosearch) is a leading supplier of sophisticated oligonucleotide components to the rapidly ...
Page 5 of 24« First...34567...1020...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS